ClinicalTrials.govpublic full text
A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies
genital neoplasms, female, ovarian cancer, cervical cancer, uterine cancer, fallopian tube cancer, endometrial cancer, vaginal cancer, peritoneal cancer, reproductive cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1007605
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.